Hormonal strategies in gynecologic cancer: Bridging biology and therapy

Gynecol Oncol. 2018 Aug;150(2):207-210. doi: 10.1016/j.ygyno.2018.06.005. Epub 2018 Jun 20.

Authors

Wilberto Nieves-Neira¹, J Julie Kim¹, Daniela Matei²

Affiliations

¹ Department of Obstetrics and Gynecology, Northwestern University, United States; Robert H. Lurie Comprehensive Cancer Center, Chicago, IL 60611, United States.
² Department of Obstetrics and Gynecology, Northwestern University, United States; Robert H. Lurie Comprehensive Cancer Center, Chicago, IL 60611, United States. Electronic address: daniela.matei@northwestern.edu.

PMID: 29933928
DOI: 10.1016/j.ygyno.2018.06.005

No abstract available

Publication types

Editorial

MeSH terms

Animals
Aromatase Inhibitors / administration & dosage
Endometrial Neoplasms / drug therapy
Endometrial Neoplasms / metabolism*
Endometrial Neoplasms / pathology
Endometrial Neoplasms / therapy*
Female
Fertility Preservation / methods
Hormones / metabolism*
Humans
Progestins / administration & dosage
Signal Transduction
Stromal Cells / pathology
TOR Serine-Threonine Kinases / antagonists & inhibitors

Substances

Aromatase Inhibitors
Hormones
Progestins
TOR Serine-Threonine Kinases